Magnetic resonance (MR) imaging is widely used for diagnostic imaging in medicine as it is considered a safe alternative to ionizing radiation-based techniques. Recent reports on potential genotoxic effects of strong and fast switching electromagnetic gradients such as used in cardiac MR (CMR) have raised safety concerns. The aim of this study was to analyse DNA double-strand breaks (DSBs) in human blood lymphocytes before and after CMR examination.
Introduction
Magnetic resonance (MR) imaging is a widely used and wellestablished non-invasive medical diagnostic imaging tool. By using a static and a gradient magnetic field in combination with a radiofrequency field (RF), MR provides excellent contrast among different tissues of the body including the brain, musculoskeletal system, and the heart. Although long-term effects on human health from exposure to strong static magnetic fields seem unlikely, 1 acute effects such as vertigo, nausea, change in blood pressure, reversible arrhythmia, 2 and neurobehavioural effects have been documented from occupational exposition to 1.5 T. 3 Cardiac MR (CMR) imaging requires some of the strongest and fastest switching electromagnetic gradients available in MR exposing the patients to the highest administered energy levels accepted by the controlling authorities. 4 Studies focusing on experimental teratogenic 5 -9 or carcinogenic 10 -12 effects of MR revealed conflicting results. Since CMR is emerging as one of the fastest growing new fields of broad MR application, 13 it is of particular concern that a recent in vitro study with CMR sequences has reported on CMR-induced DNA damages in white blood cells up to 24 h after exposure to 1.5 T CMR. 4 in order to evaluate adverse biological effects of clinical MR scanning.
The aim of the present study was to assess the impact of routine CMR scanning on DNA double-strand breaks (DSBs) of peripheral blood mononuclear cells (PBMCs) as a measure of the carcinogenic potential of this examination.
Methods
Twenty consecutive patients referred for cardiac evaluation were included. After obtaining written informed consent, 10 mL of peripheral blood was drawn before and after undergoing routine contrast (gadobutrolum, Gadovist, Bayer Schering Pharma, Germany) enhanced CMR examination 18 on a 1.5 T MR scanner (Philips Achieva, Best, NL, USA) as approved by the local ethics committee (KEK-Nr. 849). PBMCs were obtained using density gradient separation (Histopaque 1077, Sigma-Aldrich) as previously established. 19 The clinical CMR protocol used in our daily routine has been recently reported in detail. 20 In brief, a commercially available MR scanner (Philips 1.5 T, Achieva, software release 3.2.1) equipped with a maximum gradient strength of 42 mT/m and a maximum gradient speed of 180 mT/m/ms was used. The following standard pulse sequences to generate images were used: gradient echo, steady-state free precession, FastSE, T 2 -weighted double-inversion black-blood spin-echo sequence for oedema imaging, balanced SSFP sequence for perfusion and inversion recovery segmented gradient echo sequence for late gadolinium enhancement. DSBs were detected by immunofluorescence microscopy using a rabbit-anti-human phospho-histone g-H2AX and a goat-anti-rabbitAlexaFluor-488 antibody (CST Cell Signalling Technology, adapted from May et al.
21
). Cell nuclei were counterstained with 4 ′ ,6-diamidino-2-phenylindole (DAPI, Vector Laboratories) and the g-H2AX foci per lymphocyte were visualized on an inverse confocal microscope (CLSM-Model SP5, Leica Microsystems) and quantified by a blinded observer.
With flow cytometry (FACScanto, BD Bioscience), DSBs were additionally quantified in T-lymphocytes 22, 23 previously identified by a mouse-anti-human CD3-APC antibody (Life Technologies). Based on forward and side light scattering, PBMCs were gated for viable single-cell events and proper compensation controls were used in flow cytometric analyses to correct for spectral overlap. Data from flow cytometric quantification (MFI, geometric mean of fluorescence intensity of g-H2AXpositive T-lymphocytes) was evaluated using FlowJo software (V10.0.2, Tree Star, Inc.). Based on a variation of g-H2AX assessment at 20% as reported by Muslimovic et al., 22 an average difference in g-H2AX findings reported in ex vivo experiments, 4 aiming at alpha ¼ 0.05 and a power (1 2 b) of 0.8, the number of patients necessary was calculated between 10 and 15. SPSS 20.0 (SPSS, Chicago, IL, USA) was used for all statistical analysis. The Shapiro-Wilk test was applied to exclude normal distribution of data sets. This was followed by testing for significant differences between DSBs before and after CMR examination by using the Wilcoxon signed-rank test. P-values of ,0.05 (two-tailed) were considered statistically significant.
Results
Mean age of patients was 53 + 13 years and 16 (80%) were males. Ten patients were referred for evaluation of cardiomyopathy and 10 for the assessment of myocardial ischaemia. The mean CMR scan duration was 68 + 22 min with an average contrast media bolus of 15 + 4 mL. The patient baseline characteristics are given in Table 1 .
By immunofluorescence microscopy ( Figure 1) , the median number of DSBs (foci, Table 2 ) per lymphocyte in baseline samples was 0.066 (range: 0-0.661) and increased significantly (P , 0.05) after CMR exposure to 0.190 (range: 0-1.065, Figure 2 ).
In T-lymphocytes, flow cytometry ( Figure 3 ) revealed a median MFI (arbitrary units) of 2758 (range: 1907-5109) before and 3232 (range: 2413-5484) after CMR (P , 0.005, Table 2 and Figure 4 ).
Discussion
We show here that clinical routine CMR scanning exerts genotoxic effects. Although many experimental in vitro studies have suggested DNA damage after exposure to MR imaging, we present the first in vivo results documenting that contrast CMR scanning in daily clinical routine is associated with increased lymphocyte DNA damage.
The different components of the magnetic field during CMR may have contributed to the observed DNA damage. The gradient field generated during MR scanning includes extremely low frequencies (ELF), which have been classified by the International Agency for Research on Cancer (IARC) as possible human carcinogen (group 2B) 24 based on a large body of literature on the genotoxic effects of ELF magnetic fields. 25 -28 The latter seem to be involved directly and indirectly in DNA and chromosomal damage by inducing reactive oxygen species. 29 Similarly, DNA damage and chromosome alterations have been discussed after exposure to RF. Our results do not allow commenting on the persistence of the induced DNA damage, although this is a key issue of genetic risk assessment, because damage can trigger DNA instability and exert tumourigenic effects. Due to the long time delay between DSB induction and resulting cancer development, our study cannot quantify such long-term effects as this was beyond the scope of the present study. This, however, is true in principle for any observation of DSB Impact of cardiac magnetic resonance imaging Figure 1 Visualization of double-strand breaks (DSBs) in nuclei (arrow heads) of human lymphocytes of two patients before and after cardiac magnetic resonance scans by immunofluorescence microscopy. DSBs (foci, white arrows) are detected by g-H2AX staining (green).
induction from any diagnostic radiation exposure including ionizing radiation, for which no direct observational proof of its adverse impact on outcome is available due to the small scale of damage and the long delay between exposure and event. In view of the growing use of new generation MR scanners with increasing magnetic field strength (higher Tesla), our results seem to support the suggestions of the ICNIRP for an urgent need of monitoring workers and for epidemiologic studies on subjects with high levels of exposure or particular conditions such as for example pregnant occupational workers. 30 Despite activation of repair mechanisms, persistence of DNA damage has been found in human lymphocytes more than 24 h after exposing patients and blood samples to CMR scanning. 4 Co-genotoxic effects of MR in combination with the administered gadolinium-based contrast material may further have contributed to DNA damage due to the potentiating effect of gadolinium-based contrast material and MR exposure. 31 As in our study all patients underwent contrast enhanced CMR, reflecting widely used clinical practice, 32 we cannot differentiate the precise contribution of the known genotoxic effect of the gadolinium-based contrast material from the effects of the magnetic field. However, the use of contrast material is generally an integrated part of CMR scanning and therefore our results may appropriately represent the effect of a routine CMR scan. The absolute amount of DNA damage is certainly larger in our study compared with previous in vitro studies, as the entire blood of each patient rather than a blood sample was exposed during CMR. According to the assumptions used in the field of radiation protection, an increased number of DNA damages confer a linearly increased risk of cancer. Conversely, even a low number of DSBs may represent a carcinogenic risk according to the linear-no threshold theory. Our results compare well to the more than two-fold increase in DSBs induced by CMR and assessed by immunofluorescence microscopy as reported by Simi et al., 4 which was substantially less pronounced than the almost six-fold increase observed after cardiac CT by Kuefner et al. 33 Although only a few data are available using FACS analyses for this low scale of signal, the excellent agreement between microscopy and FACS over a large range of signal including the present study strengthens the validity of our results. 34 Of note, observations in several subsets of patients seem to suggest increased sensibilities to MRI exposition, as higher susceptibility for DNA damage by MRI has been found for example in lymphocytes of patients with Turner's syndrome. 35 Thus, inappropriate examinations should be avoided and CMR should be used with caution and similar restrictions may apply as for X-ray-based and nuclear imaging techniques where the potential harm is carefully weighted against the obvious benefit offered by each examination in order to avoid unnecessary damage of DNA integrity with potential carcinogenic effect. 
